Literature DB >> 8149655

Cytokines and autoimmunity.

M G Cavallo1, P Pozzilli, R Thorpe.   

Abstract

Although the immunopathology of most autoimmune diseases has been well defined, the mechanisms responsible for the breakdown of self-tolerance and which lead to the development of systemic and organ-specific autoaggression are still unclear. Evidence has accumulated which supports a role for a disregulated production of cytokines by leucocytes and possibly other cells in the pathogenesis of some autoimmune diseases. However, due to the complexity and heterogeneity of cytokine effects in the regulation of the immune response, it is difficult to determine whether abnormalities in the patterns of cytokine production are primary or secondary to the pathological process. Confusion is also caused by the fact that the biological activities of cytokines are multiple and often overlapping, and consequently it is difficult to focus on a unique effect of any one cytokine. Characterization of the potential and actual involvement of cytokines is important not only for a better understanding of the pathogenesis of autoimmune conditions, but particularly because of the implications for the development of immunotherapeutic strategies for the prevention and treatment of the diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149655      PMCID: PMC1534543          DOI: 10.1111/j.1365-2249.1994.tb06220.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  93 in total

Review 1.  MHC molecules and beta-cell destruction. Immune and nonimmune mechanisms.

Authors:  L C Harrison; I L Campbell; J Allison; J F Miller
Journal:  Diabetes       Date:  1989-07       Impact factor: 9.461

2.  Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans.

Authors:  J P Palmer; S Helqvist; G A Spinas; J Mølvig; T Mandrup-Poulsen; H U Andersen; J Nerup
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

Review 3.  Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group.

Authors:  K Bendtzen; K Buschard; M Diamant; T Horn; M Svenson
Journal:  Lymphokine Res       Date:  1989

Review 4.  The role of interleukin 2 in autoimmunity.

Authors:  G Kroemer; G Wick
Journal:  Immunol Today       Date:  1989-07

5.  Lack of association of HLA-DR4 with interleukin 1 beta secretion from peripheral blood monocytes in patients with rheumatoid arthritis.

Authors:  M Goto; M Sasano; T Miyamoto; K Nishioka; K Nakamura; S Aotsuka; R Yokohari
Journal:  J Rheumatol       Date:  1989-08       Impact factor: 4.666

6.  Evidence for IL-6 production by and effects on the pancreatic beta-cell.

Authors:  I L Campbell; A Cutri; A Wilson; L C Harrison
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

7.  Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection.

Authors:  I L Campbell; A Cutri; D Wilkinson; A W Boyd; L C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6.

Authors:  B Grubeck-Loebenstein; G Buchan; D Chantry; H Kassal; M Londei; K Pirich; K Barrett; M Turner; W Waldhausl; M Feldmann
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

9.  Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.

Authors:  J Satoh; H Seino; T Abo; S Tanaka; S Shintani; S Ohta; K Tamura; T Sawai; T Nobunaga; T Oteki
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

10.  MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.

Authors:  E H Leiter; G J Christianson; D V Serreze; A T Ting; S M Worthen
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.

Authors:  A Nandoskar; J Raffel; A S Scalfari; T Friede; R S Nicholas
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

2.  Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?

Authors:  G Rostoker; J C Rymer; G Bagnard; M Petit-Phar; M Griuncelli; Y Pilatte
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 3.  Genetic background and environment contribute synergistically to the onset of autoimmune diseases.

Authors:  P Luppi; M R Rossiello; S Faas; M Trucco
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

Review 4.  Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential.

Authors:  Saikat Mitra; Maniza Muni; Nusrat Jahan Shawon; Rajib Das; Talha Bin Emran; Rohit Sharma; Deepak Chandran; Fahadul Islam; Md Jamal Hossain; Sher Zaman Safi; Sherouk Hussein Sweilam
Journal:  Oxid Med Cell Longev       Date:  2022-08-18       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.